Permission to Sue

Former Pfizer oncology director Delina Ferretti has been given permission by a federal judge to sue Pfizer under whistleblower laws regarding alleged bad clinical trial results hidden by the company from US Food and Drug Administration regulators, reports Pharmalot's Ed Silverman. Two years ago, Ferretti claimed she noticed a problem with a drug in Phase I testing, and that adverse events from that trial weren't being reported to FDA.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.